Home/PathCision Medicine/David Lee, M.D., Ph.D.
DL

David Lee, M.D., Ph.D.

CSO & Co-Founder

PathCision Medicine

Therapeutic Areas

PathCision Medicine Pipeline

DrugIndicationPhase
UndisclosedOncology (starting with metastatic cancer)Preclinical